Tomorrow I arrive in Stockholm, Sweden, for the European Society of Cardiology’s (ESC) 2010 Congress, along with immediate past president Fred Bove, MD, MACC, ACC President-Elect David Holmes, MD, FACC, ACC Vice President William Zoghbi, MD, FACC, and Jack Lewin (co-author of this blog and ACC CEO). With the full leadership team present, we’ll meet with the leadership of  other major cardiovascular societies – ESC, SCAI, American Heart Association, the World Heart Federation – other with many smaller international cardiovascular societies, like the Turkish Society of Cardiology, Saudi Heart Association, Israel Heart Society, Society of Cardiology of the Russian Federation, Hellenic Cardiological Society, Mexican Society of Cardiology, among others. Fred and Dick Conte will be performing many interviews for our ACCEL program along with important meetings led by Tony DeMaria for our JACC journal editors.  I also will have the honor of chairing a late breaking trials session on Tuesday: “Hot Line III – Cardiovascular Disease and Rhythm Disturbances.”

It’s bound to be an exciting and informative couple of days. You don’t have to be there to learn about the latest clinical content coming out of the meeting – CardioSource.org will be providing updates each day on the hottest trials to be released. Below are the trials that are expected to be hot:

• ALPHA OMEGA
• CURE ACTIVE
• ART
• AVERROES
• EINSTEIN DVT

Beginning on Sunday, check back to http://www.cardiosource.org/Science-And-Quality.aspx for summaries and presentation slides for these trials.

< Back to Listings